Research map: Fc-optimized GITR antibody enhances a CD4 T cell–dendritic cell crosstalk to promote antitumor immunity
Back to the article
Papers in this map
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
· Yingyao Zhou · 2019 · 16082 citations · Cited by this paper
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study
· 2026 · Related
The PRIDE database at 20 years: 2025 update
· Yasset Pérez‐Riverol · 2024 · 2054 citations · Cited by this paper
GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells
· 2026 · Related
Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity
· Robert L. Shields · 2002 · 1850 citations · Cited by this paper
PAPOLA-mediated hyperactive polyadenylation promotes leukemogenesis and leukemia stem cell self-renewal through metabolic reprogramming
· 2026 · Related
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
· Tyler R. Simpson · 2013 · 1504 citations · Cited by this paper
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial
· 2026 · Related
Decisions About Dendritic Cells: Past, Present, and Future
· Ralph M. Steinman · 2012 · 1275 citations · Cited by this paper
Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases
· 2026 · Related
Immune checkpoint therapy—current perspectives and future directions
· Padmanee Sharma · 2023 · 1195 citations · Cited by this paper
Oncolytic viruses and cytokine-based gene therapies reprogram the tumor microenvironment
· 2026 · Related
UCell: Robust and scalable single-cell gene signature scoring
· Massimo Andreatta · 2021 · 1158 citations · Cited by this paper
Targeting PID1 generates oxysterols to switch macrophage cell fates for improved antitumor immunity
· 2026 · Related
A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration
· Thorsten Buch · 2005 · 968 citations · Cited by this paper
Bacterial engineering for cancer therapy
· 2026 · Related
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
· Lukas Kraehenbuehl · 2021 · 905 citations · Cited by this paper
A high-MAPK, low-WNT cell state drives metastatic dissemination in colorectal cancer
· 2026 · Related
In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy
· Sean P. Arlauckas · 2017 · 679 citations · Cited by this paper
DeepFAN, a transformer-based model for human–artificial intelligence collaborative assessment of incidental pulmonary nodules in CT scans: a multireader, multicase trial
· 2026 · Related
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
· Falk Nimmerjahn · 2005 · 666 citations · Cited by this paper
cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity
· Stephen T. Ferris · 2020 · 621 citations · Cited by this paper
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
· Frederick Arce Vargas · 2018 · 594 citations · Cited by this paper
An efficient route to human bispecific IgG
· A. Margaret Merchant · 1998 · 522 citations · Cited by this paper
Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage
· Matthew M. Meredith · 2012 · 522 citations · Cited by this paper
Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
· Wolfgang M. Schäfer · 2011 · 492 citations · Cited by this paper
Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox
· David Yoonsuk Oh · 2021 · 468 citations · Cited by this paper
Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies
· Yannick Bulliard · 2013 · 459 citations · Cited by this paper
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
· Frederick Arce Vargas · 2017 · 437 citations · Cited by this paper
Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma
· Assaf Magen · 2023 · 429 citations · Cited by this paper
The promise and challenges of immune agonist antibody development in cancer
· Patrick A. Mayes · 2018 · 360 citations · Cited by this paper
Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
· Fubin Li · 2011 · 338 citations · Cited by this paper
Mouse model recapitulating human Fcγ receptor structural and functional diversity
· Patrick T Smith · 2012 · 323 citations · Cited by this paper
Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells
· John O. Richards · 2008 · 312 citations · Cited by this paper
OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy
· Yannick Bulliard · 2014 · 299 citations · Cited by this paper
Impact of Immune Complex Size and Glycosylation on IgG Binding to Human FcγRs
· Anja Lux · 2013 · 276 citations · Cited by this paper
Rational design of anti-GITR-based combination immunotherapy
· Roberta Zappasodi · 2019 · 234 citations · Cited by this paper
Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
· Ann L. White · 2011 · 230 citations · Cited by this paper
CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity
· Isabelle Solomon · 2020 · 207 citations · Cited by this paper
Source: OpenAlex (CC0)